Mogamulizumab for HTLV-related Adult T Cell Leukemia/Lymphoma

Chapter 2

In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses an important study on the efficacy of mogamulizumab in patients with human T cell lymphotropic virus (HTLV)-related adult T cell leukemia/lymphoma.

Chapter 1

HTLV-related Adult T Cell Leukemia/Lymphoma: Research in the United States

In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses her research into human T cell lymphotropic virus (HTLV)-related adult T cell leukemia/lymphoma, including a study in which she and colleagues were able to identify 4 prognostic features in this setting.

Chapter 3

Tailoring Treatments in Adult T Cell Leukemia/Lymphoma

In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses some ongoing research into precision medicine for patients with non-Hodgkin lymphoma.

Chapter 4

Specializing Care in Adult T Cell Leukemia/Lymphoma

In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses her and experience with treating adult T cell leukemia/lymphoma, as well as a number of ongoing trials in the area.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs